We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Pultegroup
PHM
$24.8B
| $1.64M | 0.01% |
39,072
+21,130
| +118% | +$1.05M |
|
1652
Tronox
TROX
$993M
| $1.63M | 0.01% |
82,584
-145,074
| -64% | -$3.15M |
|
1653
Cardlytics
CDLX
$22.4M
| $1.63M | 0.01% |
2,971
+897
| +43% | +$542K |
|
1654
Designer Brands
DBI
$334M
| $1.63M | 0.01% |
120,880
-122,405
| -50% | -$1.62M |
|
|
FYBR
1655
DELISTED
Frontier Communications
FYBR
| $1.63M | 0.01% |
59,012
-54,481
| -48% | -$1.5M |
|
1656
Voyager Therapeutics
VYGR
$195M
| $1.63M | 0.01% |
214,184
+193,661
| +944% | +$864K |
|
|
AVDX
1657
DELISTED
AvidXchange
AVDX
| $1.63M | 0.01% |
202,468
+155,857
| +334% | +$1.57M |
|
|
NKGN
1658
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $1.63M | 0.01% |
167,975
-6,530
| -4% | -$63.3K |
|
|
USCTU
1659
DELISTED
Roth CH Acquisition Co. Unit
USCTU
| $1.63M | 0.01% |
161,207
-2,170
| -1% | -$21.9K |
|
|
INFA
1660
DELISTED
Informatica
INFA
| $1.63M | 0.01% |
82,311
+5,660
| +7% | +$136K |
|
1661
MarineMax
HZO
$1.15B
| $1.62M | 0.01% |
40,350
+6,254
| +18% | +$294K |
|
1662
Fossil Group
FOSL
$317M
| $1.62M | 0.01% |
+168,347
| New | +$1.91M |
|
|
ROSE
1663
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
| $1.62M | 0.01% |
162,122
+90,098
| +125% | +$898K |
|
1664
Veeco
VECO
$3.02B
| $1.62M | 0.01% |
59,612
+28,835
| +94% | +$813K |
|
|
CTRA
1665
DELISTED
Coterra Energy
CTRA
| $1.62M | 0.01% |
60,048
-111,086
| -65% | -$2.6M |
|
1666
StoneX
SNEX
$7.81B
| $1.62M | 0.01% |
+110,307
| New | +$1.53M |
|
1667
Enovis
ENOV
$1.4B
| $1.61M | 0.01% |
23,586
-33,444
| -59% | -$2.38M |
|
1668
Stratasys
SSYS
$769M
| $1.61M | 0.01% |
63,591
-161,076
| -72% | -$3.88M |
|
1669
United Natural Foods
UNFI
$2.8B
| $1.61M | 0.01% |
39,029
-46,141
| -54% | -$1.89M |
|
1670
Tevogen Inc. Common Stock
TVGN
$27M
| $1.61M | 0.01% |
+3,230
| New | +$1.61M |
|
|
BHVN
1671
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.61M | 0.01% |
13,586
+8,941
| +192% | +$1.12M |
|
1672
Wabtec
WAB
$49.7B
| $1.61M | 0.01% |
16,706
+7,745
| +86% | +$717K |
|
1673
Cracker Barrel
CBRL
$1.25B
| $1.6M | 0.01% |
13,515
-45,784
| -77% | -$5.68M |
|
|
WRAC
1674
DELISTED
Williams Rowland Acquisition Corp.
WRAC
| $1.6M | 0.01% |
160,731
+37,896
| +31% | +$376K |
|
1675
Mercer International
MERC
$34.2M
| $1.6M | 0.01% |
114,782
+85,219
| +288% | +$1.1M |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.